BioSpace

Argenx buyout of peptide engine and Big Pharma favorite UNP could top $1B

Unnatural Products has risen from founder Joshua Schwochert’s garage to an acquisition deal, valued at up to $1.15 billion, to join argenx.

By BioSpace

1 min read
Argenx buyout of peptide engine and Big Pharma favorite UNP could top $1B
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights